Antonijoan Arbós, R. M. (. M., Ferrero-Cafiero, J. M., Coimbra, J., Puntes, M., Martínez-Colomer, J., Arévalo, M. I., . . . Maes, T. (2021). First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.
Citación estilo ChicagoAntonijoan Arbós, Rosa Ma (Rosa María)|||0000-0002-7099-5125, et al. First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat. 2021.
Cita MLAAntonijoan Arbós, Rosa Ma (Rosa María)|||0000-0002-7099-5125, et al. First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat. 2021.
Precaución: Estas citas no son 100% exactas.